Curemark Competitors and Similar CompaniesClear all
Synthorx's competitors and similar companies include Incendia Therapeutics and AM Pharma.
 Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. |  Incendia Therapeutics Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment. | ||
Founding Date | Founding Date 2014 | Founding Date 2019 | Founding Date 2001 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Boston, US HQ | Locations Utrecht, NL HQ Utrecht, NL |
Employees | Employees 3939% increase | Employees 41 | Employees 28 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 65m (over 4 years ago) | Latest funding round $ 24m (about 6 years ago) |
Total funding raised | Total funding raised $ 79m | Total funding raised $ 65m | Total funding raised $ 210.3m |
For sources of this data, please see the company profile
View Company Profiles
Incendia Therapeutics
HQ
Boston, US
Employees
41
Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment.
View company
AM Pharma
HQ
Utrecht, NL
Employees
28
AM-Pharma is a biopharmaceutical company that develops medicines for patients.
View company